Cannabis Use Is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users

Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on reward/aversion regions implicated in addiction, such as the nucleus accumbens and amygdala. Animal studies show structural changes in brain regions such a...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 34; no. 16; pp. 5529 - 5538
Main Authors Gilman, Jodi M., Kuster, John K., Lee, Sang, Lee, Myung Joo, Kim, Byoung Woo, Makris, Nikos, van der Kouwe, Andre, Blood, Anne J., Breiter, Hans C.
Format Journal Article
LanguageEnglish
Published United States Society for Neuroscience 16.04.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on reward/aversion regions implicated in addiction, such as the nucleus accumbens and amygdala. Animal studies show structural changes in brain regions such as the nucleus accumbens after exposure to Δ9-tetrahydrocannabinol, but less is known about cannabis use and brain morphometry in these regions in humans. We collected high-resolution MRI scans on young adult recreational marijuana users and nonusing controls and conducted three independent analyses of morphometry in these structures: (1) gray matter density using voxel-based morphometry, (2) volume (total brain and regional volumes), and (3) shape (surface morphometry). Gray matter density analyses revealed greater gray matter density in marijuana users than in control participants in the left nucleus accumbens extending to subcallosal cortex, hypothalamus, sublenticular extended amygdala, and left amygdala, even after controlling for age, sex, alcohol use, and cigarette smoking. Trend-level effects were observed for a volume increase in the left nucleus accumbens only. Significant shape differences were detected in the left nucleus accumbens and right amygdala. The left nucleus accumbens showed salient exposure-dependent alterations across all three measures and an altered multimodal relationship across measures in the marijuana group. These data suggest that marijuana exposure, even in young recreational users, is associated with exposure-dependent alterations of the neural matrix of core reward structures and is consistent with animal studies of changes in dendritic arborization.
AbstractList Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on reward/aversion regions implicated in addiction, such as the nucleus accumbens and amygdala. Animal studies show structural changes in brain regions such as the nucleus accumbens after exposure to Δ9-tetrahydrocannabinol, but less is known about cannabis use and brain morphometry in these regions in humans. We collected high-resolution MRI scans on young adult recreational marijuana users and nonusing controls and conducted three independent analyses of morphometry in these structures: (1) gray matter density using voxel-based morphometry, (2) volume (total brain and regional volumes), and (3) shape (surface morphometry). Gray matter density analyses revealed greater gray matter density in marijuana users than in control participants in the left nucleus accumbens extending to subcallosal cortex, hypothalamus, sublenticular extended amygdala, and left amygdala, even after controlling for age, sex, alcohol use, and cigarette smoking. Trend-level effects were observed for a volume increase in the left nucleus accumbens only. Significant shape differences were detected in the left nucleus accumbens and right amygdala. The left nucleus accumbens showed salient exposure-dependent alterations across all three measures and an altered multimodal relationship across measures in the marijuana group. These data suggest that marijuana exposure, even in young recreational users, is associated with exposure-dependent alterations of the neural matrix of core reward structures and is consistent with animal studies of changes in dendritic arborization.
Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on reward/aversion regions implicated in addiction, such as the nucleus accumbens and amygdala. Animal studies show structural changes in brain regions such as the nucleus accumbens after exposure to Δ9-tetrahydrocannabinol, but less is known about cannabis use and brain morphometry in these regions in humans. We collected high-resolution MRI scans on young adult recreational marijuana users and nonusing controls and conducted three independent analyses of morphometry in these structures: (1) gray matter density using voxel-based morphometry, (2) volume (total brain and regional volumes), and (3) shape (surface morphometry). Gray matter density analyses revealed greater gray matter density in marijuana users than in control participants in the left nucleus accumbens extending to subcallosal cortex, hypothalamus, sublenticular extended amygdala, and left amygdala, even after controlling for age, sex, alcohol use, and cigarette smoking. Trend-level effects were observed for a volume increase in the left nucleus accumbens only. Significant shape differences were detected in the left nucleus accumbens and right amygdala. The left nucleus accumbens showed salient exposure-dependent alterations across all three measures and an altered multimodal relationship across measures in the marijuana group. These data suggest that marijuana exposure, even in young recreational users, is associated with exposure-dependent alterations of the neural matrix of core reward structures and is consistent with animal studies of changes in dendritic arborization.Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on reward/aversion regions implicated in addiction, such as the nucleus accumbens and amygdala. Animal studies show structural changes in brain regions such as the nucleus accumbens after exposure to Δ9-tetrahydrocannabinol, but less is known about cannabis use and brain morphometry in these regions in humans. We collected high-resolution MRI scans on young adult recreational marijuana users and nonusing controls and conducted three independent analyses of morphometry in these structures: (1) gray matter density using voxel-based morphometry, (2) volume (total brain and regional volumes), and (3) shape (surface morphometry). Gray matter density analyses revealed greater gray matter density in marijuana users than in control participants in the left nucleus accumbens extending to subcallosal cortex, hypothalamus, sublenticular extended amygdala, and left amygdala, even after controlling for age, sex, alcohol use, and cigarette smoking. Trend-level effects were observed for a volume increase in the left nucleus accumbens only. Significant shape differences were detected in the left nucleus accumbens and right amygdala. The left nucleus accumbens showed salient exposure-dependent alterations across all three measures and an altered multimodal relationship across measures in the marijuana group. These data suggest that marijuana exposure, even in young recreational users, is associated with exposure-dependent alterations of the neural matrix of core reward structures and is consistent with animal studies of changes in dendritic arborization.
Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on reward/aversion regions implicated in addiction, such as the nucleus accumbens and amygdala. Animal studies show structural changes in brain regions such as the nucleus accumbens after exposure to [Delta]9-tetrahydrocannabinol, but less is known about cannabis use and brain morphometry in these regions in humans. We collected high-resolution MRI scans on young adult recreational marijuana users and nonusing controls and conducted three independent analyses of morphometry in these structures: (1) gray matter density using voxel-based morphometry, (2) volume (total brain and regional volumes), and (3) shape (surface morphometry). Gray matter density analyses revealed greater gray matter density in marijuana users than in control participants in the left nucleus accumbens extending to subcallosal cortex, hypothalamus, sublenticular extended amygdala, and left amygdala, even after controlling for age, sex, alcohol use, and cigarette smoking. Trend-level effects were observed for a volume increase in the left nucleus accumbens only. Significant shape differences were detected in the left nucleus accumbens and right amygdala. The left nucleus accumbens showed salient exposure-dependent alterations across all three measures and an altered multimodal relationship across measures in the marijuana group. These data suggest that marijuana exposure, even in young recreational users, is associated with exposure-dependent alterations of the neural matrix of core reward structures and is consistent with animal studies of changes in dendritic arborization.
Author Gilman, Jodi M.
van der Kouwe, Andre
Breiter, Hans C.
Lee, Myung Joo
Kuster, John K.
Blood, Anne J.
Lee, Sang
Kim, Byoung Woo
Makris, Nikos
Author_xml – sequence: 1
  givenname: Jodi M.
  surname: Gilman
  fullname: Gilman, Jodi M.
– sequence: 2
  givenname: John K.
  surname: Kuster
  fullname: Kuster, John K.
– sequence: 3
  givenname: Sang
  surname: Lee
  fullname: Lee, Sang
– sequence: 4
  givenname: Myung Joo
  surname: Lee
  fullname: Lee, Myung Joo
– sequence: 5
  givenname: Byoung Woo
  surname: Kim
  fullname: Kim, Byoung Woo
– sequence: 6
  givenname: Nikos
  surname: Makris
  fullname: Makris, Nikos
– sequence: 7
  givenname: Andre
  surname: van der Kouwe
  fullname: van der Kouwe, Andre
– sequence: 8
  givenname: Anne J.
  surname: Blood
  fullname: Blood, Anne J.
– sequence: 9
  givenname: Hans C.
  surname: Breiter
  fullname: Breiter, Hans C.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24741043$$D View this record in MEDLINE/PubMed
BookMark eNqFkkFv1DAQhS1URLeFv1D5yCVbO3biREJI0arQRVUrSnvgZDn2ZGvk2CV2ivbAf8dLywq49GRp5nvPM5p3hA588IDQCSVLWpXs9NPl2e311ZfVeskFrwrKliWh_AVa5G5blJzQA7QgpSBFnYFDdBTjN0KIIFS8QodlrlHC2QL9XCnvVW8jvo2A1xF_npVPNqlkH8BtcRdj0FYlMPiHTXf4ctYO5og7reexBx-x8gZ343ZjlFO4632YRuVsshCx9fhrmP0Gd2Z2CV-DniAbB6_c7rspvkYvB-UivHl6j9HNh7Ob1XlxcfVxveouCs25SAUlom4FE0YRplpBDTDDQAyiraGty9qovmdD2YiGqIrwypCBGDPwvuJ0yMJj9P7R9n7uRzAafJqUk_eTHdW0lUFZ-W_H2zu5CQ-StU3DSZsN3j4ZTOH7DDHJ0UYNzikPYY6SNqVoGkEb_jxaUdHkdWqW0ZO_x9rP8-c6GagfAT2FGCcY9gglchcDuY-B3MVAUiZ3McjCd_8J9e-Tht161j0n_wW9brvN
CitedBy_id crossref_primary_10_1016_j_addbeh_2018_10_007
crossref_primary_10_1016_j_bpsgos_2024_100361
crossref_primary_10_1080_07448481_2020_1751171
crossref_primary_10_1517_14656566_2016_1114101
crossref_primary_10_1016_j_pharmthera_2018_10_006
crossref_primary_10_1016_j_msard_2021_102830
crossref_primary_10_3389_fpsyt_2018_00175
crossref_primary_10_1038_s41598_017_01275_5
crossref_primary_10_1124_pr_115_010967
crossref_primary_10_1016_j_drugalcdep_2019_05_012
crossref_primary_10_1073_pnas_1415297111
crossref_primary_10_1016_j_nicl_2021_102664
crossref_primary_10_1016_j_pcl_2019_08_004
crossref_primary_10_1007_s40429_018_0233_8
crossref_primary_10_1111_adb_12652
crossref_primary_10_1016_j_pscychresns_2023_111613
crossref_primary_10_1038_s41380_019_0577_z
crossref_primary_10_3390_biomedicines12030681
crossref_primary_10_1007_s00213_017_4606_9
crossref_primary_10_3389_fpsyt_2019_01005
crossref_primary_10_1016_j_bbr_2024_115150
crossref_primary_10_1111_add_14629
crossref_primary_10_1007_s11934_020_01031_9
crossref_primary_10_1002_brb3_459
crossref_primary_10_1177_00243639221141223
crossref_primary_10_1371_journal_pone_0132322
crossref_primary_10_1017_S0033291718002672
crossref_primary_10_1016_j_biopsych_2015_08_024
crossref_primary_10_1016_j_pscychresns_2019_04_011
crossref_primary_10_17826_cumj_1349328
crossref_primary_10_2174_1389201023666220614145535
crossref_primary_10_5937_zdravzast50_35543
crossref_primary_10_1016_j_addbeh_2015_12_008
crossref_primary_10_3174_ajnr_A8215
crossref_primary_10_3389_fpsyt_2020_00859
crossref_primary_10_1002_cncr_30185
crossref_primary_10_1038_s41386_021_01226_9
crossref_primary_10_3389_fpsyt_2021_643193
crossref_primary_10_1097_01_NT_0000450999_79976_60
crossref_primary_10_1007_s11926_016_0625_5
crossref_primary_10_1007_s40429_016_0102_2
crossref_primary_10_1080_00325481_2018_1413281
crossref_primary_10_1016_j_pediatrneurol_2016_09_004
crossref_primary_10_1007_s40615_020_00915_3
crossref_primary_10_1016_j_biopsych_2015_11_013
crossref_primary_10_1002_ppul_23836
crossref_primary_10_1038_npp_2015_295
crossref_primary_10_1007_s40429_020_00335_7
crossref_primary_10_4303_jdar_236017
crossref_primary_10_3390_ijms24065251
crossref_primary_10_5409_wjcp_v11_i1_1
crossref_primary_10_1111_adb_13169
crossref_primary_10_1093_pch_21_1_31
crossref_primary_10_1016_j_euroneuro_2018_04_003
crossref_primary_10_1016_j_addbeh_2019_106152
crossref_primary_10_1016_j_nicl_2016_06_006
crossref_primary_10_1080_09687637_2016_1209645
crossref_primary_10_1016_j_econedurev_2018_08_003
crossref_primary_10_1111_adb_12874
crossref_primary_10_1177_1758835919866362
crossref_primary_10_1016_j_pnpbp_2020_109897
crossref_primary_10_1007_s00406_019_00979_1
crossref_primary_10_1016_j_brainres_2014_11_034
crossref_primary_10_1097_OGX_0000000000000685
crossref_primary_10_4236_jbbs_2020_108022
crossref_primary_10_1016_j_prrv_2016_11_001
crossref_primary_10_1016_j_pscychresns_2018_03_008
crossref_primary_10_3389_fpubh_2019_00311
crossref_primary_10_1016_j_neuropharm_2021_108500
crossref_primary_10_1002_jnr_23901
crossref_primary_10_1017_S1092852915000395
crossref_primary_10_1097_YCO_0000000000000150
crossref_primary_10_1016_j_euroneuro_2023_05_005
crossref_primary_10_33590_emjneurol_21_07_suppl_3
crossref_primary_10_1016_j_neuint_2022_105406
crossref_primary_10_1177_20503121211000909
crossref_primary_10_1016_j_pscychresns_2015_09_009
crossref_primary_10_3389_fpsyt_2023_1083334
crossref_primary_10_1016_j_ypmed_2017_06_004
crossref_primary_10_1093_abm_kax027
crossref_primary_10_1016_j_dcn_2015_10_004
crossref_primary_10_3758_s13415_016_0421_8
crossref_primary_10_1111_pme_12736
crossref_primary_10_1177_1087054716640109
crossref_primary_10_1007_s00429_018_1690_5
crossref_primary_10_1007_s00415_017_8715_5
crossref_primary_10_1523_JNEUROSCI_3375_17_2018
crossref_primary_10_1007_s00213_020_05608_7
crossref_primary_10_1017_S0954579424000804
crossref_primary_10_3389_fpsyt_2017_00285
crossref_primary_10_1177_1077559515620853
crossref_primary_10_1523_JNEUROSCI_2946_14_2015
crossref_primary_10_1017_S0033291715002342
crossref_primary_10_3389_fpsyt_2021_745193
crossref_primary_10_1007_s12519_024_00828_9
crossref_primary_10_1016_j_dcn_2015_04_006
crossref_primary_10_1080_00243639_2015_1125083
crossref_primary_10_1177_0024363920916284
crossref_primary_10_1007_s40429_017_0141_3
crossref_primary_10_1016_j_drugalcdep_2015_06_016
crossref_primary_10_1080_00952990_2019_1634086
crossref_primary_10_3390_brainsci13050787
crossref_primary_10_1093_cercor_bhaa087
crossref_primary_10_1016_j_pscychresns_2017_03_007
crossref_primary_10_1016_j_biopsych_2020_09_021
crossref_primary_10_1001_jamapsychiatry_2018_4500
crossref_primary_10_1371_journal_pone_0155302
crossref_primary_10_1111_soin_12359
crossref_primary_10_1177_13591053211002248
crossref_primary_10_1007_s11481_018_9782_9
crossref_primary_10_1038_s41398_021_01382_y
crossref_primary_10_1016_j_psychres_2020_113588
crossref_primary_10_1089_can_2021_0099
crossref_primary_10_3899_jrheum_150103
crossref_primary_10_4103_ijpn_ijpn_1_21
crossref_primary_10_1016_j_jadohealth_2014_05_006
crossref_primary_10_3389_fphar_2014_00259
crossref_primary_10_1016_j_euroneuro_2016_08_015
crossref_primary_10_3934_publichealth_2019_1_4
crossref_primary_10_7759_cureus_28361
crossref_primary_10_1038_s41386_022_01413_2
crossref_primary_10_1002_hbm_25131
crossref_primary_10_1007_s11469_020_00226_y
crossref_primary_10_1038_s41598_022_22313_x
crossref_primary_10_1111_add_14084
crossref_primary_10_1038_s41386_019_0347_2
crossref_primary_10_1001_jamapsychiatry_2018_0335
crossref_primary_10_1016_j_drugpo_2017_10_003
crossref_primary_10_1521_jscp_2019_38_6_451
crossref_primary_10_1016_j_neulet_2021_136141
crossref_primary_10_1523_JNEUROSCI_0190_17_2017
crossref_primary_10_2217_ijr_14_34
crossref_primary_10_1080_00913847_2024_2375788
crossref_primary_10_1371_journal_pone_0152482
crossref_primary_10_3389_fncel_2016_00264
crossref_primary_10_1038_mp_2017_200
crossref_primary_10_1177_1090198120965509
crossref_primary_10_1089_can_2017_0030
crossref_primary_10_3917_psyt_232_0111
crossref_primary_10_1176_appi_focus_17204
crossref_primary_10_3390_medicina55070396
crossref_primary_10_1016_j_drugalcdep_2016_09_002
crossref_primary_10_15252_embr_201439742
crossref_primary_10_1007_s00429_015_1158_9
crossref_primary_10_1007_s13311_015_0375_5
crossref_primary_10_1111_ajad_12270
crossref_primary_10_1177_20503245221095228
crossref_primary_10_1016_j_cobeha_2016_10_004
crossref_primary_10_1016_j_jbusvent_2020_106088
crossref_primary_10_1586_14737175_2014_985209
crossref_primary_10_1111_add_14252
crossref_primary_10_1016_S1474_4422_14_70251_0
crossref_primary_10_1177_0269881117718380
crossref_primary_10_1016_j_dcn_2015_05_005
crossref_primary_10_1080_00952990_2017_1306746
crossref_primary_10_1159_000533524
crossref_primary_10_1177_02698811221117523
crossref_primary_10_1590_1415_4714_2018v21n4p715_3
crossref_primary_10_1111_bph_13581
crossref_primary_10_1016_S1042_0991_15_30855_0
crossref_primary_10_1093_pm_pnx143
crossref_primary_10_1016_j_drugalcdep_2016_01_032
crossref_primary_10_1371_journal_pone_0149764
crossref_primary_10_1016_j_pscychresns_2017_09_003
crossref_primary_10_1016_j_spen_2023_101052
crossref_primary_10_1016_j_pscychresns_2016_05_009
crossref_primary_10_1016_j_josat_2024_209472
crossref_primary_10_1016_j_ctcp_2020_101154
crossref_primary_10_1016_j_bpsc_2018_02_006
crossref_primary_10_1111_ajad_13093
crossref_primary_10_1093_ijnp_pyv061
crossref_primary_10_3390_brainsci10020102
crossref_primary_10_1016_j_jebo_2018_07_003
Cites_doi 10.1111/j.1360-0443.1993.tb02093.x
10.1053/scnp.2001.22927
10.1016/j.euroneuro.2003.08.005
10.1136/jnnp.23.1.56
10.1097/WNR.0b013e3282fa6db9
10.1016/j.drugalcdep.2004.06.011
10.1046/j.1460-9568.1999.00576.x
10.1073/pnas.191355898
10.1016/j.cogbrainres.2005.02.016
10.1007/BF02245916
10.1016/S0009-9120(02)00325-9
10.1002/hbm.20595
10.1002/ana.410250110
10.1016/S0006-8993(00)02739-6
10.1002/syn.20106
10.1136/bmj.326.7396.942
10.1016/j.neuron.2004.10.027
10.1186/1471-2377-8-8
10.1016/j.pscychresns.2006.08.006
10.1080/07448480309595719
10.1002/hbm.1058
10.1192/bjp.bp.109.067314
10.1006/nimg.2000.0582
10.1006/nimg.1998.0384
10.1016/0306-4603(86)90040-7
10.1073/pnas.92.26.12304
10.1363/3401508
10.1016/j.biopsych.2006.08.027
10.1002/ajmg.b.30944
10.1016/j.media.2009.05.004
10.1371/journal.pone.0031654
10.1007/978-1-4757-0145-6_1
10.3109/10826084.2010.482443
10.1001/archpsyc.65.6.694
10.1016/S0092-6566(03)00046-1
10.1016/S0896-6273(01)00303-8
10.1097/00001756-200112210-00024
10.1016/S0896-6273(02)00569-X
10.1038/npp.2009.110
10.1016/j.neuroimage.2005.03.035
10.1016/j.neuroimage.2007.12.025
10.1371/journal.pone.0013945
10.1016/S0893-133X(01)00371-2
10.1038/sj.bjp.0705931
10.1038/npp.2012.92
10.1073/pnas.0703472104
10.1016/j.neuron.2008.08.011
10.1523/JNEUROSCI.2134-04.2004
10.1016/S0896-6273(00)80374-8
10.1016/j.neuroimage.2011.09.046
10.1523/JNEUROSCI.0086-08.2008
10.1176/ajp.156.1.11
10.1523/JNEUROSCI.2571-07.2007
10.1038/clpt.2010.318
10.1093/cercor/4.4.344
10.1002/syn.20313
10.1176/appi.neuropsych.18.3.318
ContentType Journal Article
Copyright Copyright © 2014 the authors 0270-6474/14/345529-10$15.00/0 2014
Copyright_xml – notice: Copyright © 2014 the authors 0270-6474/14/345529-10$15.00/0 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
5PM
DOI 10.1523/JNEUROSCI.4745-13.2014
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList
MEDLINE - Academic
Neurosciences Abstracts
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1529-2401
EndPage 5538
ExternalDocumentID PMC3988409
24741043
10_1523_JNEUROSCI_4745_13_2014
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: PHS HHS
  grantid: NIDA 026104
– fundername: PHS HHS
  grantid: NIDA 14118
– fundername: NIDA NIH HHS
  grantid: K01 DA034093
– fundername: PHS HHS
  grantid: NIDA 027804
– fundername: PHS HHS
  grantid: NIDA 026002
– fundername: PHS HHS
  grantid: NIDA 034093
– fundername: PHS HHS
  grantid: NINDS 052368
GroupedDBID ---
-DZ
-~X
.55
18M
2WC
34G
39C
53G
5GY
5RE
5VS
AAFWJ
AAJMC
AAYXX
ABBAR
ABIVO
ACGUR
ACNCT
ADBBV
ADCOW
ADHGD
AENEX
AETEA
AFCFT
AFOSN
AFSQR
AHWXS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
H13
HYE
H~9
KQ8
L7B
OK1
P0W
P2P
QZG
R.V
RHI
RPM
TFN
TR2
W8F
WH7
WOQ
X7M
XJT
YBU
YHG
YKV
YNH
YSK
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
5PM
ID FETCH-LOGICAL-c447t-10769737da03a971de3d3e7f796e9626dabb3f28780a5045d0f0ddf4b541f973
ISSN 0270-6474
1529-2401
IngestDate Thu Aug 21 18:37:10 EDT 2025
Thu Jul 10 18:20:20 EDT 2025
Fri Jul 11 13:42:06 EDT 2025
Thu Apr 03 07:08:39 EDT 2025
Tue Jul 01 03:47:11 EDT 2025
Thu Apr 24 23:09:00 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 16
Keywords reward
cannabis
marijuana
topology/shape
multimodal imaging
gray matter density
Language English
License https://creativecommons.org/licenses/by-nc-sa/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c447t-10769737da03a971de3d3e7f796e9626dabb3f28780a5045d0f0ddf4b541f973
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
A.J.B. and H.C.B. contributed equally to this work.
Author contributions: J.M.G., M.J.L., B.K., N.M., A.J.v.d.K., A.B., and H.C.B. designed research; J.M.G., J.K.K., S.L., and A.J.v.d.K. performed research; M.J.L., B.K., A.B., and H.C.B. contributed unpublished reagents/analytic tools; J.M.G., J.K.K., S.L., M.J.L., N.M., A.B., and H.C.B. analyzed data; J.M.G., A.B., and H.C.B. wrote the paper.
J.K.K., S.L., and M.J.L. contributed equally to this work.
OpenAccessLink https://www.jneurosci.org/content/jneuro/34/16/5529.full.pdf
PMID 24741043
PQID 1517876963
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3988409
proquest_miscellaneous_1827887184
proquest_miscellaneous_1517876963
pubmed_primary_24741043
crossref_primary_10_1523_JNEUROSCI_4745_13_2014
crossref_citationtrail_10_1523_JNEUROSCI_4745_13_2014
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-04-16
PublicationDateYYYYMMDD 2014-04-16
PublicationDate_xml – month: 04
  year: 2014
  text: 2014-04-16
  day: 16
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of neuroscience
PublicationTitleAlternate J Neurosci
PublicationYear 2014
Publisher Society for Neuroscience
Publisher_xml – name: Society for Neuroscience
References 2023041304102392000_34.16.5529.3
2023041304102392000_34.16.5529.27
2023041304102392000_34.16.5529.2
2023041304102392000_34.16.5529.26
2023041304102392000_34.16.5529.5
2023041304102392000_34.16.5529.25
2023041304102392000_34.16.5529.4
2023041304102392000_34.16.5529.24
2023041304102392000_34.16.5529.7
2023041304102392000_34.16.5529.23
2023041304102392000_34.16.5529.6
2023041304102392000_34.16.5529.22
2023041304102392000_34.16.5529.9
2023041304102392000_34.16.5529.21
2023041304102392000_34.16.5529.8
2023041304102392000_34.16.5529.20
2023041304102392000_34.16.5529.61
2023041304102392000_34.16.5529.60
2023041304102392000_34.16.5529.1
2023041304102392000_34.16.5529.19
2023041304102392000_34.16.5529.18
2023041304102392000_34.16.5529.17
2023041304102392000_34.16.5529.38
2023041304102392000_34.16.5529.37
2023041304102392000_34.16.5529.36
2023041304102392000_34.16.5529.35
2023041304102392000_34.16.5529.34
2023041304102392000_34.16.5529.33
2023041304102392000_34.16.5529.32
2023041304102392000_34.16.5529.31
2023041304102392000_34.16.5529.30
2023041304102392000_34.16.5529.29
2023041304102392000_34.16.5529.28
2023041304102392000_34.16.5529.49
2023041304102392000_34.16.5529.48
2023041304102392000_34.16.5529.47
2023041304102392000_34.16.5529.46
2023041304102392000_34.16.5529.45
2023041304102392000_34.16.5529.44
2023041304102392000_34.16.5529.43
2023041304102392000_34.16.5529.42
2023041304102392000_34.16.5529.41
2023041304102392000_34.16.5529.40
Childress (2023041304102392000_34.16.5529.14) 1999; 156
2023041304102392000_34.16.5529.39
2023041304102392000_34.16.5529.16
2023041304102392000_34.16.5529.15
2023041304102392000_34.16.5529.59
2023041304102392000_34.16.5529.58
2023041304102392000_34.16.5529.13
2023041304102392000_34.16.5529.57
2023041304102392000_34.16.5529.12
2023041304102392000_34.16.5529.56
2023041304102392000_34.16.5529.11
2023041304102392000_34.16.5529.55
2023041304102392000_34.16.5529.10
2023041304102392000_34.16.5529.54
2023041304102392000_34.16.5529.53
2023041304102392000_34.16.5529.52
2023041304102392000_34.16.5529.51
2023041304102392000_34.16.5529.50
19525140 - Med Image Anal. 2009 Aug;13(4):543-63
15795138 - Brain Res Cogn Brain Res. 2005 Apr;23(1):107-18
9892292 - Am J Psychiatry. 1999 Jan;156(1):11-8
21289620 - Clin Pharmacol Ther. 2011 Mar;89(3):400-7
9918726 - Neuroimage. 1999 Jan;9(1):18-45
22384048 - PLoS One. 2012;7(2):e31654
15635590 - Synapse. 2005 Mar 1;55(3):183-91
10860804 - Neuroimage. 2000 Jun;11(6 Pt 1):805-21
14399272 - J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
15541319 - Neuron. 2004 Nov 18;44(4):729-40
14717576 - J Am Coll Health. 2003 Jul-Aug;52(1):17-24
20118463 - Br J Psychiatry. 2010 Feb;196(2):150-7
18440913 - Int Fam Plan Perspect. 2008 Mar;34(1):15-20
14636960 - Eur Neuropsychopharmacol. 2003 Dec;13(6):442-52
7950308 - Cereb Cortex. 1994 Jul-Aug;4(4):344-60
11747097 - Hum Brain Mapp. 2002 Jan;15(1):1-25
17239356 - Biol Psychiatry. 2007 Jun 1;61(11):1281-9
18940597 - Neuron. 2008 Oct 9;60(1):174-88
11447572 - Semin Clin Neuropsychiatry. 2001 Jul;6(3):205-16
11742222 - Neuroreport. 2001 Dec 21;12(18):3973-8
12493577 - Clin Biochem. 2002 Oct;35(7):501-11
15525780 - J Neurosci. 2004 Nov 3;24(44):9953-61
3739800 - Addict Behav. 1986;11(2):149-61
11573015 - Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11818-23
16963581 - J Neuropsychiatry Clin Neurosci. 2006 Summer;18(3):318-32
21982932 - Neuroimage. 2012 Feb 15;59(4):3845-51
18382272 - Neuroreport. 2008 Apr 16;19(6):609-13
19388013 - Am J Med Genet B Neuropsychiatr Genet. 2009 Sep 5;150B(6):762-81
17535893 - Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9800-5
18448634 - J Neurosci. 2008 Apr 30;28(18):4583-91
15313883 - Br J Pharmacol. 2004 Sep;143(2):227-34
12727737 - BMJ. 2003 May 3;326(7396):942-3
1776564 - Adv Exp Med Biol. 1991;295:1-42
9331351 - Neuron. 1997 Sep;19(3):591-611
17289354 - Psychiatry Res. 2007 Feb 28;154(2):181-90
18242102 - Neuroimage. 2008 Apr 1;40(2):559-69
10215912 - Eur J Neurosci. 1999 May;11(5):1598-604
11395019 - Neuron. 2001 May;30(2):619-39
21124764 - PLoS One. 2010;5(11):e13945
11832223 - Neuron. 2002 Jan 31;33(3):341-55
11850152 - Neuropsychopharmacology. 2002 Mar;26(3):376-86
15607838 - Drug Alcohol Depend. 2005 Jan 7;77(1):23-30
20590400 - Subst Use Misuse. 2010 Sep;45(11):1787-808
2177204 - Psychopharmacology (Berl). 1990;102(2):156-62
18077695 - J Neurosci. 2007 Dec 12;27(50):13835-42
18570200 - Hum Brain Mapp. 2009 Apr;30(4):1236-45
22669173 - Neuropsychopharmacology. 2012 Oct;37(11):2368-76
15886023 - Neuroimage. 2005 Aug 1;27(1):222-30
18519827 - Arch Gen Psychiatry. 2008 Jun;65(6):694-701
8329970 - Addiction. 1993 Jun;88(6):791-804
19710631 - Neuropsychopharmacology. 2010 Jan;35(1):217-38
16881072 - Synapse. 2006 Nov;60(6):429-36
8618890 - Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12304-8
10986361 - Brain Res. 2000 Sep 22;877(2):407-10
18412976 - BMC Neurol. 2008;8:8
2643919 - Ann Neurol. 1989 Jan;25(1):61-7
References_xml – ident: 2023041304102392000_34.16.5529.54
  doi: 10.1111/j.1360-0443.1993.tb02093.x
– ident: 2023041304102392000_34.16.5529.5
  doi: 10.1053/scnp.2001.22927
– ident: 2023041304102392000_34.16.5529.39
  doi: 10.1016/j.euroneuro.2003.08.005
– ident: 2023041304102392000_34.16.5529.29
  doi: 10.1136/jnnp.23.1.56
– ident: 2023041304102392000_34.16.5529.36
  doi: 10.1097/WNR.0b013e3282fa6db9
– ident: 2023041304102392000_34.16.5529.47
  doi: 10.1016/j.drugalcdep.2004.06.011
– ident: 2023041304102392000_34.16.5529.53
  doi: 10.1046/j.1460-9568.1999.00576.x
– ident: 2023041304102392000_34.16.5529.6
  doi: 10.1073/pnas.191355898
– ident: 2023041304102392000_34.16.5529.28
  doi: 10.1016/j.cogbrainres.2005.02.016
– ident: 2023041304102392000_34.16.5529.13
  doi: 10.1007/BF02245916
– ident: 2023041304102392000_34.16.5529.22
  doi: 10.1016/S0009-9120(02)00325-9
– ident: 2023041304102392000_34.16.5529.15
  doi: 10.1002/hbm.20595
– ident: 2023041304102392000_34.16.5529.18
  doi: 10.1002/ana.410250110
– ident: 2023041304102392000_34.16.5529.41
  doi: 10.1016/S0006-8993(00)02739-6
– ident: 2023041304102392000_34.16.5529.26
  doi: 10.1002/syn.20106
– ident: 2023041304102392000_34.16.5529.34
  doi: 10.1136/bmj.326.7396.942
– ident: 2023041304102392000_34.16.5529.45
  doi: 10.1016/j.neuron.2004.10.027
– ident: 2023041304102392000_34.16.5529.48
  doi: 10.1186/1471-2377-8-8
– ident: 2023041304102392000_34.16.5529.60
  doi: 10.1016/j.pscychresns.2006.08.006
– ident: 2023041304102392000_34.16.5529.49
  doi: 10.1080/07448480309595719
– ident: 2023041304102392000_34.16.5529.50
  doi: 10.1002/hbm.1058
– ident: 2023041304102392000_34.16.5529.31
  doi: 10.1192/bjp.bp.109.067314
– ident: 2023041304102392000_34.16.5529.3
  doi: 10.1006/nimg.2000.0582
– ident: 2023041304102392000_34.16.5529.44
  doi: 10.1006/nimg.1998.0384
– ident: 2023041304102392000_34.16.5529.56
  doi: 10.1016/0306-4603(86)90040-7
– ident: 2023041304102392000_34.16.5529.51
  doi: 10.1073/pnas.92.26.12304
– ident: 2023041304102392000_34.16.5529.23
  doi: 10.1363/3401508
– ident: 2023041304102392000_34.16.5529.35
  doi: 10.1016/j.biopsych.2006.08.027
– ident: 2023041304102392000_34.16.5529.24
  doi: 10.1002/ajmg.b.30944
– ident: 2023041304102392000_34.16.5529.32
  doi: 10.1016/j.media.2009.05.004
– ident: 2023041304102392000_34.16.5529.8
  doi: 10.1371/journal.pone.0031654
– ident: 2023041304102392000_34.16.5529.33
  doi: 10.1007/978-1-4757-0145-6_1
– ident: 2023041304102392000_34.16.5529.42
  doi: 10.3109/10826084.2010.482443
– ident: 2023041304102392000_34.16.5529.61
  doi: 10.1001/archpsyc.65.6.694
– ident: 2023041304102392000_34.16.5529.27
  doi: 10.1016/S0092-6566(03)00046-1
– ident: 2023041304102392000_34.16.5529.11
  doi: 10.1016/S0896-6273(01)00303-8
– ident: 2023041304102392000_34.16.5529.17
  doi: 10.1097/00001756-200112210-00024
– ident: 2023041304102392000_34.16.5529.21
  doi: 10.1016/S0896-6273(02)00569-X
– ident: 2023041304102392000_34.16.5529.57
– ident: 2023041304102392000_34.16.5529.40
  doi: 10.1038/npp.2009.110
– ident: 2023041304102392000_34.16.5529.58
  doi: 10.1016/j.neuroimage.2005.03.035
– ident: 2023041304102392000_34.16.5529.59
  doi: 10.1016/j.neuroimage.2007.12.025
– ident: 2023041304102392000_34.16.5529.2
– ident: 2023041304102392000_34.16.5529.7
  doi: 10.1371/journal.pone.0013945
– ident: 2023041304102392000_34.16.5529.9
  doi: 10.1016/S0893-133X(01)00371-2
– ident: 2023041304102392000_34.16.5529.20
– ident: 2023041304102392000_34.16.5529.43
  doi: 10.1038/sj.bjp.0705931
– ident: 2023041304102392000_34.16.5529.55
  doi: 10.1038/npp.2012.92
– ident: 2023041304102392000_34.16.5529.12
  doi: 10.1073/pnas.0703472104
– ident: 2023041304102392000_34.16.5529.46
  doi: 10.1016/j.neuron.2008.08.011
– ident: 2023041304102392000_34.16.5529.4
  doi: 10.1523/JNEUROSCI.2134-04.2004
– ident: 2023041304102392000_34.16.5529.10
  doi: 10.1016/S0896-6273(00)80374-8
– ident: 2023041304102392000_34.16.5529.16
  doi: 10.1016/j.neuroimage.2011.09.046
– ident: 2023041304102392000_34.16.5529.25
  doi: 10.1523/JNEUROSCI.0086-08.2008
– volume: 156
  start-page: 11
  year: 1999
  ident: 2023041304102392000_34.16.5529.14
  article-title: Limbic activation during cue-induced cocaine craving
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.156.1.11
– ident: 2023041304102392000_34.16.5529.1
– ident: 2023041304102392000_34.16.5529.30
  doi: 10.1523/JNEUROSCI.2571-07.2007
– ident: 2023041304102392000_34.16.5529.37
  doi: 10.1038/clpt.2010.318
– ident: 2023041304102392000_34.16.5529.19
  doi: 10.1093/cercor/4.4.344
– ident: 2023041304102392000_34.16.5529.38
  doi: 10.1002/syn.20313
– ident: 2023041304102392000_34.16.5529.52
  doi: 10.1176/appi.neuropsych.18.3.318
– reference: 18519827 - Arch Gen Psychiatry. 2008 Jun;65(6):694-701
– reference: 11850152 - Neuropsychopharmacology. 2002 Mar;26(3):376-86
– reference: 20590400 - Subst Use Misuse. 2010 Sep;45(11):1787-808
– reference: 16881072 - Synapse. 2006 Nov;60(6):429-36
– reference: 11747097 - Hum Brain Mapp. 2002 Jan;15(1):1-25
– reference: 14399272 - J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
– reference: 11573015 - Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11818-23
– reference: 15607838 - Drug Alcohol Depend. 2005 Jan 7;77(1):23-30
– reference: 21289620 - Clin Pharmacol Ther. 2011 Mar;89(3):400-7
– reference: 18570200 - Hum Brain Mapp. 2009 Apr;30(4):1236-45
– reference: 11832223 - Neuron. 2002 Jan 31;33(3):341-55
– reference: 15541319 - Neuron. 2004 Nov 18;44(4):729-40
– reference: 12727737 - BMJ. 2003 May 3;326(7396):942-3
– reference: 19388013 - Am J Med Genet B Neuropsychiatr Genet. 2009 Sep 5;150B(6):762-81
– reference: 12493577 - Clin Biochem. 2002 Oct;35(7):501-11
– reference: 18382272 - Neuroreport. 2008 Apr 16;19(6):609-13
– reference: 9892292 - Am J Psychiatry. 1999 Jan;156(1):11-8
– reference: 18440913 - Int Fam Plan Perspect. 2008 Mar;34(1):15-20
– reference: 18412976 - BMC Neurol. 2008;8:8
– reference: 10986361 - Brain Res. 2000 Sep 22;877(2):407-10
– reference: 18242102 - Neuroimage. 2008 Apr 1;40(2):559-69
– reference: 22669173 - Neuropsychopharmacology. 2012 Oct;37(11):2368-76
– reference: 15525780 - J Neurosci. 2004 Nov 3;24(44):9953-61
– reference: 18077695 - J Neurosci. 2007 Dec 12;27(50):13835-42
– reference: 8618890 - Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12304-8
– reference: 15886023 - Neuroimage. 2005 Aug 1;27(1):222-30
– reference: 1776564 - Adv Exp Med Biol. 1991;295:1-42
– reference: 11447572 - Semin Clin Neuropsychiatry. 2001 Jul;6(3):205-16
– reference: 22384048 - PLoS One. 2012;7(2):e31654
– reference: 16963581 - J Neuropsychiatry Clin Neurosci. 2006 Summer;18(3):318-32
– reference: 20118463 - Br J Psychiatry. 2010 Feb;196(2):150-7
– reference: 10215912 - Eur J Neurosci. 1999 May;11(5):1598-604
– reference: 14717576 - J Am Coll Health. 2003 Jul-Aug;52(1):17-24
– reference: 21982932 - Neuroimage. 2012 Feb 15;59(4):3845-51
– reference: 19710631 - Neuropsychopharmacology. 2010 Jan;35(1):217-38
– reference: 2177204 - Psychopharmacology (Berl). 1990;102(2):156-62
– reference: 9331351 - Neuron. 1997 Sep;19(3):591-611
– reference: 11742222 - Neuroreport. 2001 Dec 21;12(18):3973-8
– reference: 15795138 - Brain Res Cogn Brain Res. 2005 Apr;23(1):107-18
– reference: 9918726 - Neuroimage. 1999 Jan;9(1):18-45
– reference: 11395019 - Neuron. 2001 May;30(2):619-39
– reference: 2643919 - Ann Neurol. 1989 Jan;25(1):61-7
– reference: 17535893 - Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9800-5
– reference: 3739800 - Addict Behav. 1986;11(2):149-61
– reference: 18448634 - J Neurosci. 2008 Apr 30;28(18):4583-91
– reference: 10860804 - Neuroimage. 2000 Jun;11(6 Pt 1):805-21
– reference: 14636960 - Eur Neuropsychopharmacol. 2003 Dec;13(6):442-52
– reference: 15635590 - Synapse. 2005 Mar 1;55(3):183-91
– reference: 21124764 - PLoS One. 2010;5(11):e13945
– reference: 17289354 - Psychiatry Res. 2007 Feb 28;154(2):181-90
– reference: 17239356 - Biol Psychiatry. 2007 Jun 1;61(11):1281-9
– reference: 7950308 - Cereb Cortex. 1994 Jul-Aug;4(4):344-60
– reference: 18940597 - Neuron. 2008 Oct 9;60(1):174-88
– reference: 8329970 - Addiction. 1993 Jun;88(6):791-804
– reference: 19525140 - Med Image Anal. 2009 Aug;13(4):543-63
– reference: 15313883 - Br J Pharmacol. 2004 Sep;143(2):227-34
SSID ssj0007017
Score 2.532886
Snippet Marijuana is the most commonly used illicit drug in the United States, but little is known about its effects on the human brain, particularly on...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 5529
SubjectTerms Adolescent
Adult
Amygdala - pathology
Female
Humans
Image Processing, Computer-Assisted
Magnetic Resonance Imaging
Male
Marijuana Smoking - pathology
Marijuana Smoking - physiopathology
Nucleus Accumbens - pathology
Organ Size
Severity of Illness Index
Young Adult
Title Cannabis Use Is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users
URI https://www.ncbi.nlm.nih.gov/pubmed/24741043
https://www.proquest.com/docview/1517876963
https://www.proquest.com/docview/1827887184
https://pubmed.ncbi.nlm.nih.gov/PMC3988409
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKcuGCgOWxvGQkxKVKN46dODlW1S7b7lKEtpV6i5zagUpdB5H2UCR-BP-YseM8yq5g4RK1bhy3_r6OZ8bjGYTeBiaHleSRF4VEeSzJAk8EIvIEi4OExIpF0gbITqOzOZsswkWv97MTtbTdZIPl9xvPlfwPqtAGuJpTsv-AbPNQaIDXgC9cAWG43grjkdBaZKuyPy9Vf1yaCE1tD42BCFvvmqmvI8ynJnfxtjQVIkwdEF2lZx5e7T5LsRb9YaaNAru2OVaNH8RKgv7QZOjoqJeA6bx0cfO1WtseMLOqbSdJZsOb96u1c7ZOCrlqnbDn27o2iA3iabyuLkLoUriltW36sDNfa1IUXY8FsYEu1YFKJ9gCDiYrq6rzDJQTvIHd6SFdyezcnI6BXTkbhs5PotzbKkXMtfUgtHkpJlMTFnk5Gg9g0NAj1IT0sXYFrHf9px_T0_nFRTo7WczuoLsBWB6mKMb5pzYBPfdtEefmJ7hD5zDO8c2j7Os714yY32NxO8rN7AG676DDw4piD1FP6UfocKjFprja4XfYxgnbDZhD9KNmHQYa4HGJ91mHW9ZhwzrsWIcb1mFgHa5Zh_dYh1caW9ZhyzrcZR22rHuMZqcns9GZ54p4eEvG-AaWeR4lnHIpfCoSTqSikiqe8yRSCVjTUmQZzcFuj30Rgn0h_dyXMmdZyEgOHZ-gA11o9QxhUFZznwaSZjC_vogSKUUuY9CZM0EViY9QWM90unQJ7k2dlXVqDF1AKG0QSg1CKaGpQegIHTf9vlYpXv7a400NZArS2GyxCa2KbQmdCKyAEaxqf7gnDkwIL4nhOU8r8JtxAxiG-Ax68z1aNDeYbPD7n-jVF5sVniaxcdY8v8W4L9C99n_5Eh1svm3VK9CtN9lry_ZfBRbQnQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cannabis+Use+Is+Quantitatively+Associated+with+Nucleus+Accumbens+and+Amygdala+Abnormalities+in+Young+Adult+Recreational+Users&rft.jtitle=The+Journal+of+neuroscience&rft.au=Gilman%2C+Jodi+M&rft.au=Kuster%2C+John+K&rft.au=Lee%2C+Sang&rft.au=Lee%2C+Myung+Joo&rft.date=2014-04-16&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=34&rft.issue=16&rft.spage=5529&rft.epage=5538&rft_id=info:doi/10.1523%2FJNEUROSCI.4745-13.2014&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon